Role of the unfolded protein response in determining the fate of tumor cells and the promise of multi-targeted therapies

Role of the unfolded protein response in determining the fate of tumor cells and the promise of multi-targeted therapies

Although there have been advances in our understanding of carcinogenesis and development of new treatments, cancer remains a common cause of death. Many regulatory pathways are incompletely understood in cancer development and progression, with a prime example being those related to the endoplasmic...

Ausführliche Beschreibung

Bibliographische Detailangaben
Veröffentlicht in:Cell Stress & Chaperones. - Elsevier. - 23(2018), 3, Seite 317-334
1. Verfasser: Shen, Kunyu (VerfasserIn)
Weitere Verfasser: Johnson, David W., Vesey, David A., McGuckin, Michael A., Gobe, Glenda C.
Format: Online-Aufsatz
Sprache:English
Veröffentlicht: 2018
Zugriff auf das übergeordnete Werk:Cell Stress & Chaperones
Schlagworte:Health sciences Behavioral sciences Physical sciences Biological sciences
LEADER 01000caa a22002652 4500
001 JST139362401
003 DE-627
005 20240626005019.0
007 cr uuu---uuuuu
008 240117s2018 xx |||||o 00| ||eng c
035 |a (DE-627)JST139362401 
035 |a (JST)44851634 
040 |a DE-627  |b ger  |c DE-627  |e rakwb 
041 |a eng 
100 1 |a Shen, Kunyu  |e verfasserin  |4 aut 
245 1 0 |a Role of the unfolded protein response in determining the fate of tumor cells and the promise of multi-targeted therapies 
264 1 |c 2018 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
520 |a Although there have been advances in our understanding of carcinogenesis and development of new treatments, cancer remains a common cause of death. Many regulatory pathways are incompletely understood in cancer development and progression, with a prime example being those related to the endoplasmic reticulum (ER). The pathological sequelae that arise from disruption of ER homeostasis are not well defined. The ER is an organelle that is responsible for secretory protein biosynthesis and the quality control of protein folding. The ER triggers an unfolded protein response (UPR) when misfolded proteins accumulate, and while the UPR acts to restore protein folding and ER homeostasis, this response can work as a switch to determine the death or survival of cells. The treatment of cancer with agents that target the UPR has shown promising outcomes. The UPR has wide crosstalk with other signaling pathways. Multi-targeted cancer therapies which target the intersections within signaling networks have shown synergistic tumoricidal effects. In the present review, the basic cellular and signaling pathways of the ER and UPR are introduced; then the crosstalk between the ER and other signaling pathways is summarized; and ultimately, the evidence that the UPR is a potential target for cancer therapy is discussed. Regulation of the UPR downstream signaling is a common therapeutic target for different tumor types. Tumoricidal effects achieved from modulating the UPR downstream signaling could be enhanced by phosphodiesterase 5 (PDE5) inhibitors. Largely untapped by Western medicine for cancer therapies are Chinese herbal medicines. This review explores and discusses the value of some Chinese herbal extracts as PDE5 inhibitors. 
540 |a © Cell Stress Society International 2018 
650 4 |a Health sciences  |x Medical conditions  |x Diseases  |x Neoplasia  |x Cancer 
650 4 |a Behavioral sciences  |x Psychology  |x Clinical psychology  |x Psychological stress 
650 4 |a Physical sciences  |x Chemistry  |x Chemical compounds  |x Chemicals  |x Polymers  |x Biopolymers  |x Proteins 
650 4 |a Biological sciences  |x Biology  |x Cytology  |x Cell biology  |x Cellular structures  |x Intracellular space  |x Organelles  |x Endoplasmic reticulum 
650 4 |a Biological sciences  |x Biology  |x Cytology  |x Cell biology  |x Cell physiology  |x Cell death  |x Apoptosis 
650 4 |a Biological sciences  |x Biology  |x Cytology  |x Cell biology  |x Cells  |x Antigen presenting cells  |x Dendritic cells 
650 4 |a Biological sciences  |x Biology  |x Genetics  |x Molecular genetics  |x Genetic translation  |x Protein synthesis  |x Post translational modification  |x Unfolded protein response 
650 4 |a Biological sciences  |x Biology  |x Physiology  |x Body composition  |x Body fluids  |x Blood  |x Blood cells  |x Leukocytes  |x Mononuclear leukocytes  |x Lymphocytes  |x T lymphocytes 
650 4 |a Physical sciences  |x Chemistry  |x Chemical compounds  |x Chemicals  |x Polymers  |x Biopolymers  |x Proteins  |x Heat shock proteins 
650 4 |a Biological sciences  |x Biology  |x Genetics  |x Molecular genetics  |x Gene expression  |x MINI REVIEW 
655 4 |a research-article 
700 1 |a Johnson, David W.  |e verfasserin  |4 aut 
700 1 |a Vesey, David A.  |e verfasserin  |4 aut 
700 1 |a McGuckin, Michael A.  |e verfasserin  |4 aut 
700 1 |a Gobe, Glenda C.  |e verfasserin  |4 aut 
773 0 8 |i Enthalten in  |t Cell Stress & Chaperones  |d Elsevier  |g 23(2018), 3, Seite 317-334  |w (DE-627)320421309  |w (DE-600)2002594-4  |x 14661268  |7 nnns 
773 1 8 |g volume:23  |g year:2018  |g number:3  |g pages:317-334 
856 4 0 |u https://www.jstor.org/stable/44851634  |3 Volltext 
912 |a GBV_USEFLAG_A 
912 |a SYSFLAG_A 
912 |a GBV_JST 
912 |a GBV_ILN_11 
912 |a GBV_ILN_20 
912 |a GBV_ILN_22 
912 |a GBV_ILN_23 
912 |a GBV_ILN_24 
912 |a GBV_ILN_31 
912 |a GBV_ILN_32 
912 |a GBV_ILN_39 
912 |a GBV_ILN_40 
912 |a GBV_ILN_60 
912 |a GBV_ILN_62 
912 |a GBV_ILN_63 
912 |a GBV_ILN_65 
912 |a GBV_ILN_69 
912 |a GBV_ILN_70 
912 |a GBV_ILN_73 
912 |a GBV_ILN_74 
912 |a GBV_ILN_90 
912 |a GBV_ILN_95 
912 |a GBV_ILN_100 
912 |a GBV_ILN_101 
912 |a GBV_ILN_105 
912 |a GBV_ILN_110 
912 |a GBV_ILN_120 
912 |a GBV_ILN_138 
912 |a GBV_ILN_150 
912 |a GBV_ILN_151 
912 |a GBV_ILN_161 
912 |a GBV_ILN_165 
912 |a GBV_ILN_170 
912 |a GBV_ILN_171 
912 |a GBV_ILN_187 
912 |a GBV_ILN_213 
912 |a GBV_ILN_224 
912 |a GBV_ILN_230 
912 |a GBV_ILN_250 
912 |a GBV_ILN_281 
912 |a GBV_ILN_285 
912 |a GBV_ILN_293 
912 |a GBV_ILN_370 
912 |a GBV_ILN_374 
912 |a GBV_ILN_602 
912 |a GBV_ILN_636 
912 |a GBV_ILN_702 
912 |a GBV_ILN_2001 
912 |a GBV_ILN_2003 
912 |a GBV_ILN_2004 
912 |a GBV_ILN_2005 
912 |a GBV_ILN_2006 
912 |a GBV_ILN_2007 
912 |a GBV_ILN_2008 
912 |a GBV_ILN_2009 
912 |a GBV_ILN_2010 
912 |a GBV_ILN_2011 
912 |a GBV_ILN_2014 
912 |a GBV_ILN_2015 
912 |a GBV_ILN_2018 
912 |a GBV_ILN_2020 
912 |a GBV_ILN_2021 
912 |a GBV_ILN_2025 
912 |a GBV_ILN_2026 
912 |a GBV_ILN_2027 
912 |a GBV_ILN_2031 
912 |a GBV_ILN_2034 
912 |a GBV_ILN_2037 
912 |a GBV_ILN_2038 
912 |a GBV_ILN_2039 
912 |a GBV_ILN_2044 
912 |a GBV_ILN_2048 
912 |a GBV_ILN_2049 
912 |a GBV_ILN_2050 
912 |a GBV_ILN_2055 
912 |a GBV_ILN_2056 
912 |a GBV_ILN_2057 
912 |a GBV_ILN_2059 
912 |a GBV_ILN_2061 
912 |a GBV_ILN_2064 
912 |a GBV_ILN_2065 
912 |a GBV_ILN_2068 
912 |a GBV_ILN_2070 
912 |a GBV_ILN_2086 
912 |a GBV_ILN_2088 
912 |a GBV_ILN_2093 
912 |a GBV_ILN_2106 
912 |a GBV_ILN_2107 
912 |a GBV_ILN_2108 
912 |a GBV_ILN_2110 
912 |a GBV_ILN_2111 
912 |a GBV_ILN_2112 
912 |a GBV_ILN_2113 
912 |a GBV_ILN_2116 
912 |a GBV_ILN_2118 
912 |a GBV_ILN_2119 
912 |a GBV_ILN_2122 
912 |a GBV_ILN_2129 
912 |a GBV_ILN_2143 
912 |a GBV_ILN_2144 
912 |a GBV_ILN_2147 
912 |a GBV_ILN_2148 
912 |a GBV_ILN_2152 
912 |a GBV_ILN_2153 
912 |a GBV_ILN_2188 
912 |a GBV_ILN_2190 
912 |a GBV_ILN_2232 
912 |a GBV_ILN_2336 
912 |a GBV_ILN_2446 
912 |a GBV_ILN_2470 
912 |a GBV_ILN_2472 
912 |a GBV_ILN_2507 
912 |a GBV_ILN_2522 
912 |a GBV_ILN_2548 
912 |a GBV_ILN_2939 
912 |a GBV_ILN_2946 
912 |a GBV_ILN_2949 
912 |a GBV_ILN_2951 
912 |a GBV_ILN_4012 
912 |a GBV_ILN_4035 
912 |a GBV_ILN_4037 
912 |a GBV_ILN_4046 
912 |a GBV_ILN_4112 
912 |a GBV_ILN_4125 
912 |a GBV_ILN_4126 
912 |a GBV_ILN_4242 
912 |a GBV_ILN_4246 
912 |a GBV_ILN_4249 
912 |a GBV_ILN_4251 
912 |a GBV_ILN_4305 
912 |a GBV_ILN_4306 
912 |a GBV_ILN_4307 
912 |a GBV_ILN_4313 
912 |a GBV_ILN_4322 
912 |a GBV_ILN_4323 
912 |a GBV_ILN_4324 
912 |a GBV_ILN_4325 
912 |a GBV_ILN_4326 
912 |a GBV_ILN_4333 
912 |a GBV_ILN_4334 
912 |a GBV_ILN_4335 
912 |a GBV_ILN_4336 
912 |a GBV_ILN_4338 
912 |a GBV_ILN_4346 
912 |a GBV_ILN_4367 
912 |a GBV_ILN_4393 
912 |a GBV_ILN_4700 
951 |a AR 
952 |d 23  |j 2018  |e 3  |h 317-334